The asymmetric synthesis of Sitagliptin, a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Journal of Chemical Research

Volumn , Issue 4, 2010, Pages 230-232

  Liu, Feng ^a   Yu, Wansheng ^a   Ou, Wenhua ^a   Wang, Xiaoke ^a   Ruan, Libo ^a   Li, Yiming ^a   Peng, Xijiang ^a   Tao, Xiaohu ^a   Pan, Xianhua ^a  

^a SHANGHAI INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Asymmetric synthesis; Diabetes; Michael addition; Sitagliptin; amino acid

Indexed keywords

EID: 77952757399     PISSN: 03082342     EISSN: None     Source Type: Journal    
DOI: 10.3184/030823410X12709912414009     Document Type: Article

References (13)

1. Robbins and Cotran pathologic basis of disease, 7th edn, 2004, Saunders, Philadelphia, pp 1194.
2. International Diabetes Federation (IDF), Diabetes Atlas, 3rd edn, December, 2006; http://www.iotf.org/diabetes.asp.
3. A. Weber, J. Med. Chem., 2004, 48, 4135.
4. D. Drucker, J. Exp. Opin. Investig. Drugs, 2003, 12, 87.
5. P. E. Wiedeman and J. M. Trevillyan, Curr. Opin. Investig. Drugs, 2003, 4, 412.
6. D. Kim, L. Wang and M. Beconi, J. Med. Chem., 2004, 48, 141.
7. Xia Ling-hong, Chin. J. New Drug. 2007, 16, 12, 979.
8. Y. Xiao, J. D. Armstrong and S. W. Krska, WO 2004085378.
9. S. D. Dreher and N. Ikemoto, WO 2004085661.
10. K. B. Hansen, J. Balsells, S. Dreher, Y. Hsiao and J. D. Armstrong III, Org. Proc. Res. Devel., 2005, 9, 634.
11. D. Kim, L. P. Wang and M. Beconi, J. Med. Chem., 2005, 48, 11, 141.
12. S. G. Davies, O. Ichihare, L. A. S. Walters, J. Chem. Soc. Perkin Trans., 1994, 1, 1141.
13. K. B. Hansen, Y. Hsiao, and F. Xu, J. Am. Chem. Soc., 2009, 131, 8798.